BioDelivery Sciences International Inc. (BDSI)

4.63
NASDAQ : Health Technology
Prev Close 4.49
Day Low/High 4.51 / 4.75
52 Wk Low/High 1.70 / 4.75
Avg Volume 558.10K
Exchange NASDAQ
Shares Outstanding 70.81M
Market Cap 317.94M
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

4 Small-Caps on My Earnings Watch List

4 Small-Caps on My Earnings Watch List

We are coming my favorite part of earnings season -- when these small-caps report.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

Trump's FDA: A Friendlier Biotech Sheriff

Trump's FDA: A Friendlier Biotech Sheriff

There still will be winners and losers, but the new administration's FDA is a net plus for the industry.

2 Recovering Biotech Names With Room to Run

2 Recovering Biotech Names With Room to Run

There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

2 Oversold Biopharmas With Big 2017 Upsides

2 Oversold Biopharmas With Big 2017 Upsides

Flexion Therapeutics and BioDelivery Sciences are well below what they once fetched.

3 Small Biotech Value Plays

3 Small Biotech Value Plays

These stocks will be great stories in the second half of 2017, and are significantly undervalued.

Welcome to the Small-Cap Biotech Mailbag!

Welcome to the Small-Cap Biotech Mailbag!

We answer recent reader questions about three of the biotech stocks we regularly cover.

BioDelivery Sciences Showing Strength

Not much action in the markets since our last update with the major indices continuing to grind slightly higher as we try to close out a solid first trading week of 2017 on a high note. Think Teva Pharmaceuticals getting oversold today on slightly r...

My Top 2017 Pick: Progenics Pharmaceuticals

My Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher this year.

Top 2017 Pick: Progenics Pharmaceuticals

Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher next year.

3 Small-Cap Biotech Names for 2017

In our last post we discussed large-cap biotech names that have been beaten up in 2016, are cheap and hopefully will see better days in 2017. Here are a few small-cap biotechs I would keep an eye on in 2017. The following is a quick rundown. Aratana...

Some 'January Effect' Stock Picks

Some 'January Effect' Stock Picks

Small-caps could also benefit from abating tax-loss selling.

Small Biotechs on My Shopping List

Small Biotechs on My Shopping List

These small-caps are woefully undervalued after getting shellacked in October.

3 Stocks for Growth in 2017

3 Stocks for Growth in 2017

BioDelivery Sciences, Progenics Pharma and Sequential Brands are off-the-radar small-caps poised for a big year in 2017.

Profiting on Small-Cap Biotech Earnings

Profiting on Small-Cap Biotech Earnings

Don't trade the headline numbers, but cash in on those traders that do.

M&A Could Ignite Next Leg Up for Biotech

M&A Could Ignite Next Leg Up for Biotech

Pharma and biotech giants now must look to small- and mid-caps to fill out pipelines and bolster growth.

Revisiting 3 Promising Small Biotechs

Revisiting 3 Promising Small Biotechs

They are oversold and lately been on the move.

A Small Biotech Sells for Less Than Cash

A Small Biotech Sells for Less Than Cash

And yet, Endocyte has a deep pipeline.

Watching Pernix as Futures Predict an Up Opening

The markets look based on the futures like they're heading for slight upwardly tilt in opening trading. Oil is touching $41 a barrel -- its best level of the year even as Russia's central bank is calling crude's recent rally "unsustainable." Of cour...

Biotech Rally Is Healing Small-Caps

Biotech Rally Is Healing Small-Caps

This sector is finally bouncing from deeply oversold levels.

4 Great Stock-ing Stuffers for 2016

4 Great Stock-ing Stuffers for 2016

These biotech/pharma picks could give you a very happy new year.

BioDelivery Is About to Start Delivering

BioDelivery Is About to Start Delivering

The company cleared an important hurdle last month.

The Buyers Don't Seem Worried

There is just too much positive action to be overly negative.

Just Winding Down

Lazy, light-volume action kicks in ahead of the long weekend.